| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2008 | US20080008680 pure mutant Interleukin-15 polypeptide; immunosuppressant; immunotherapy |
| 01/10/2008 | DE69133552C5 Deoxyribonucleic acid sequence encoding non-A, non-B hepatitis virus - obtd. Hutch C59 subgroup encoding polypeptide(s), useful as vaccines, and immuno reactive ABS for diagnosis of virus |
| 01/10/2008 | DE19933492B4 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung A conjugate for placement of a cell, or membrane compartment-specific transport of active substances, a process for its preparation and its use |
| 01/10/2008 | DE19528029B4 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 01/10/2008 | DE102006031764A1 Verfahren zur parallelen Isolierung doppel- und einzelsträngiger Nukleinsäuren sowie zur selektiven Entfernung doppelsträngiger Nukleinsäuren aus einem Gemisch von doppel- und einzelsträngigen Nukleinsäuren A method for parallel isolation of double-and single-stranded nucleic acids and double-stranded nucleic acids for the selective removal of a mixture of double and single stranded nucleic acids |
| 01/10/2008 | DE10109466B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 01/10/2008 | CA2667974A1 Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| 01/10/2008 | CA2662704A1 Rna silencing compositions and methods for the treatment of huntington's disease |
| 01/10/2008 | CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder |
| 01/10/2008 | CA2656884A1 Cellular pyrogen test |
| 01/10/2008 | CA2656777A1 Resistance to powdery mildew and absence of necrosis in cucumis sativus |
| 01/10/2008 | CA2656771A1 Small streptococcus pyogenes antigens and their use |
| 01/10/2008 | CA2656712A1 Promoter expressed in the dehiscence zone of dry fruits |
| 01/10/2008 | CA2656700A1 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/10/2008 | CA2656558A1 Method of producing factor viii proteins by recombinant methods |
| 01/10/2008 | CA2656335A1 An apparatus and method of extracting and optically analyzing an analyte from a fluid-based sample |
| 01/10/2008 | CA2656192A1 Detectable nucleic acid tag |
| 01/10/2008 | CA2656140A1 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 01/10/2008 | CA2656104A1 Tetanus toxin fragment c based imaging agents and methods, and confocal microscopy dataset processes |
| 01/10/2008 | CA2655870A1 Improved yield and stress tolerance in transgenic plants with overexpressing polypeptides comprising a b-box zinc-finger domain |
| 01/10/2008 | CA2653545A1 Transplastomic plants expressing lumen-targeted protein |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876445A1 Antibody directed against gastrin-releasing peptide precursor and use thereof |
| 01/09/2008 | EP1876244A1 Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis |
| 01/09/2008 | EP1876242A2 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation |
| 01/09/2008 | EP1876241A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2008 | EP1876240A1 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876237A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method |
| 01/09/2008 | EP1876236A1 Antibody substituting for function of blood coagulation factor viii |
| 01/09/2008 | EP1876235A1 Novel pantothenate kinase gene and use thereof |
| 01/09/2008 | EP1876234A1 Novel -galactoside- 2,3-sialyltransferase, gene encoding the same, and process for production of the same |
| 01/09/2008 | EP1876233A1 Cells capable of differentiating into cardiac muscle cells |
| 01/09/2008 | EP1876186A1 Prophylactic/therapeutic agent for cancer |
| 01/09/2008 | EP1875927A1 Methods for evaluating a compound for its effect on skin |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874946A2 Method for production of l-amino acids by fermentation |
| 01/09/2008 | EP1874939A1 Directed complementation |
| 01/09/2008 | EP1874938A1 Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants |
| 01/09/2008 | EP1874937A2 Expression cassettes for seed-preferential expression in plants |
| 01/09/2008 | EP1874936A1 Improved methods controlling gene expression |
| 01/09/2008 | EP1874935A2 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 01/09/2008 | EP1874934A2 Transformed plants accumulating terpenes |
| 01/09/2008 | EP1874933A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874932A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874931A1 Micro rna |
| 01/09/2008 | EP1874930A2 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer |
| 01/09/2008 | EP1874929A2 Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene |
| 01/09/2008 | EP1874928A1 A host cell comprising a vector for production of proteins requiring gamma-carboxylation |
| 01/09/2008 | EP1874927A1 Improved cellulases |
| 01/09/2008 | EP1874926A1 Arabinofuranosidases |
| 01/09/2008 | EP1874923A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 01/09/2008 | EP1874844A1 Hyperbranched polymers and their applications |
| 01/09/2008 | EP1874820A2 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 01/09/2008 | EP1874815A1 Modified coagulation factor viii with enhanced stability and its derivates |
| 01/09/2008 | EP1874814A1 Ion chann |
| 01/09/2008 | EP1874811A2 Methods for modulating bone formation and mineralization by modulating krc activity |
| 01/09/2008 | EP1874810A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 01/09/2008 | EP1874808A2 Catalase gene and use thereof |
| 01/09/2008 | EP1874807A2 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 01/09/2008 | EP1874802A2 Rnai therapeutic for respiratory virus infection |
| 01/09/2008 | EP1874798A1 Basic protein purification tags from thermophilic bacteria |
| 01/09/2008 | EP1874794A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns |
| 01/09/2008 | EP1874351A2 Anti-il-6 antibodies, compositions, methods and uses |
| 01/09/2008 | EP1874345A2 Immunostimulatory compositions |
| 01/09/2008 | EP1874325A2 Methods for treating infectious disease exacerbated asthma |
| 01/09/2008 | EP1874110A2 Plant promoters, terminators, genes, vectors and related transformed plants |
| 01/09/2008 | EP1651759B1 Methods and compositions for determination of glycated proteins |
| 01/09/2008 | EP1572917A4 Antibody gene transfer and recombinant aav therefor |
| 01/09/2008 | EP1556485B1 Reversible, parallel and multitask cloning method and kit |
| 01/09/2008 | EP1527086B1 Compounds binding to p-selectin |
| 01/09/2008 | EP1465922B1 Corticotropin releasing factor receptor 2 agonists |
| 01/09/2008 | EP1461426B1 Eubacterial rna-polymerase mutants for increasing heterologous gene expression |
| 01/09/2008 | EP1451320B1 Materials and methods for releasing genetic material |
| 01/09/2008 | EP1430301B1 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1404858B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/09/2008 | EP1389241B1 Polynucleotide sequencing method |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1317549B1 Isolation and sequencing of the ptsi gene of c. glutamicum |
| 01/09/2008 | EP1303593B1 Use of cyp52a2a promoter to increase gene expression in yeast |
| 01/09/2008 | EP1290129B1 Redeposition or backstain inhibition during stonewashing process |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1246927B1 Biological control by conditional dominant lethal genetic system |
| 01/09/2008 | EP1206558B1 Plants with modified polyunsaturated fatty acids |
| 01/09/2008 | EP1129196B1 Virulence genes and proteins, and their use |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | EP1127158B1 Use of dna identification techniques for the determination of genetic material of cocoa in fermented or roasted beans and chocolate |
| 01/09/2008 | EP1040189B1 Polypeptides, their production and use |
| 01/09/2008 | EP1029079B1 Diagnostics and therapeutics for chronic obstructive airway disease |
| 01/09/2008 | EP1021552B1 Transgenic lemnaceae |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 01/09/2008 | EP0828837B1 Chimeric gene comprising a dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
| 01/09/2008 | EP0802979B1 Secreted viral cmv proteins useful for vaccines and diagnostics |
| 01/09/2008 | CN101103272A Gene expression level standardization method, program, and system |
| 01/09/2008 | CN101103117A Producing hydrogen by heterologous expression of a type II NAD (P) H dehydrogenase in chlamydomonas |
| 01/09/2008 | CN101103116A Generation of plants with altered oil content |